Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Document Type
Journal ArticlePublication Date
2020-06-01Keywords
basal forebraindorsal raphe
lateral hypothalamus
laterodorsal and pedunculopontine tegmental nuclei
locus coeruleus
nucleus accumbens
parabrachial nucleus
parafacial zone
rostromedial tegmental nucleus
sleep-wake circuitry
sublaterodorsal nucleus
tuberomamillary nucleus
ventral medulla
ventral tegmental area
ventrolateral periaqueductal gray
ventrolateral preoptic area
zona incerta
Cellular and Molecular Physiology
Neuroscience and Neurobiology
Metadata
Show full item recordAbstract
Sleep-wake control is dependent upon multiple brain areas widely distributed throughout the neural axis. Historically, the monoaminergic and cholinergic neurons of the ascending arousal system were the first to be discovered, and it was only relatively recently that GABAergic and glutamatergic wake- and sleep-promoting populations have been identified. Contemporary advances in molecular-genetic tools have revealed both the complexity and heterogeneity of GABAergic NREM sleep-promoting neurons as well as REM sleep-regulating populations in the brainstem such as glutamatergic neurons in the sublaterodorsal nucleus. The sleep-wake cycle progresses from periods of wakefulness to non-rapid eye movement (NREM) sleep and subsequently rapid eye movement (REM) sleep. Each vigilance stage is controlled by multiple neuronal populations, via a complex regulation that is still incompletely understood. In recent years the field has seen a proliferation in the identification and characterization of new neuronal populations involved in sleep-wake control thanks to newer, more powerful molecular genetic tools that are able to reveal neurophysiological functions via selective activation, inhibition and lesion of neuroanatomically defined sub-types of neurons that are widespread in the brain, such as GABAergic and glutamatergic neurons.Source
Gompf HS, Anaclet C. The neuroanatomy and neurochemistry of sleep-wake control. Curr Opin Physiol. 2020 Jun;15:143-151. doi: 10.1016/j.cophys.2019.12.012. Epub 2019 Dec 31. PMID: 32647777; PMCID: PMC7347132. Link to article on publisher's site
DOI
10.1016/j.cophys.2019.12.012Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29567PubMed ID
32647777Related Resources
ae974a485f413a2113503eed53cd6c53
10.1016/j.cophys.2019.12.012
Scopus Count
Related items
Showing items related by title, author, creator and subject.
-
Differential Role of Pontomedullary Glutamatergic Neuronal Populations in Sleep-Wake ControlErickson, Evelyn T. M.; Ferrari, Loris L.; Gompf, Heinrich S.; Anaclet, Christelle (2019-07-30)Parafacial zone (PZ) GABAergic neurons play a major role in slow-wave-sleep (SWS), also called non-rapid eye movement (NREM) sleep. The PZ also contains glutamatergic neurons expressing the vesicular transporter for glutamate, isoform 2 (Vglut2). We hypothesized that PZ Vglut2-expressing (PZ(Vglut2)) neurons are also involved in sleep control, playing a synergistic role with PZ GABAergic neurons. To test this hypothesis, we specifically activated PZ(Vglut2) neurons using the excitatory chemogenetic receptor hM3Dq. Anatomical inspection of the injection sites revealed hM3Dq transfection in PZ, parabrachial nucleus (PB), sublaterodorsal nucleus (SLD) or various combinations of these three brain areas. Consistent with the known wake- and REM sleep-promoting role of PB and SLD, respectively, chemogenetic activation of PB(Vglut2) or SLD(Vglut2) resulted in wake or REM sleep enhancement. Chemogenetic activation of PZ(Vglut2) neurons did not affect sleep-wake phenotype during the mouse active period but increased wakefulness and REM sleep, similar to PB(Vglut2) and SLD(Vglut2) activation, during the rest period. To definitively confirm the role of PZ(Vglut2) neurons, we used a specific marker for PZ(Vglut2) neurons, Phox2B. Chemogenetic activation of PZ(Phox2B) neurons did not affect sleep-wake phenotype, indicating that PZ glutamatergic neurons are not sufficient to affect sleep-wake cycle. These results indicate that PZ glutamatergic neurons are not involved in sleep-wake control.
-
The nuclear experience of CPEB: implications for RNA processing and translational control.Lin, Chien-Ling; Evans, Veronica; Shen, Shihao; Xing, Yi; Richter, Joel D (2010-02-01)CPEB is a sequence-specific RNA binding protein that promotes polyadenylation-induced translation in early development, during cell cycle progression and cellular senescence, and following neuronal synapse stimulation. It controls polyadenylation and translation through other interacting molecules, most notably the poly(A) polymerase Gld2, the deadenylating enzyme PARN, and the eIF4E-binding protein Maskin. Here, we report that CPEB shuttles between the nucleus and cytoplasm and that its export occurs via the CRM1-dependent pathway. In the nucleus of Xenopus oocytes, CPEB associates with lampbrush chromosomes and several proteins involved in nuclear RNA processing. CPEB also interacts with Maskin in the nucleus as well as with CPE-containing mRNAs. Although the CPE does not regulate mRNA export, it influences the degree to which mRNAs are translationally repressed in the cytoplasm. Moreover, CPEB directly or indirectly mediates the alternative splicing of at least one pre-mRNA in mouse embryo fibroblasts as well as certain mouse tissues. We propose that CPEB, together with Maskin, binds mRNA in the nucleus to ensure tight translational repression upon export to the cytoplasm. In addition, we propose that nuclear CPEB regulates specific pre-mRNA alternative splicing.
-
SMRTE inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domainsWu, Xiaoyang; Li, Hui; Park, Eun-Ju; Chen, J. Don (2001-04-17)The silencing mediator for retinoic acid and thyroid hormone receptors (SMRT) mediates transcriptional repression by recruiting histone deacetylases (HDACs) to the DNA-bound nuclear receptor complex. The full-length SMRT (SMRTe) contains an N-terminal sequence that is highly conserved to the nuclear receptor corepressor N-CoR. To date, little is known about the activity and function of the full-length SMRTe protein, despite extensive studies on separated receptor interaction and transcriptional repression domains. Here we show that SMRTe inhibits MEF2C transcriptional activation by targeting selective HDACs to unique subnuclear domains. Indirect immunofluorescence studies with anti-SMRTe antibody reveal discrete cytoplasmic and nuclear speckles, which contain RARalpha in an RA-sensitive manner. Formation of the SMRTe nuclear speckles results in recruitment of several class I and class II HDACs to these subnuclear domains in a process depending on HDAC enzymatic activity. Intriguingly, although HDAC4 is located primarily in the cytoplasm, coexpression of SMRTe dramatically translocates HDAC4 from the cytoplasm into the nucleus, where HDAC4 prevents MEF2C from activating muscle differentiation. SMRTe also translocates HDAC5 from diffusive nucleoplasm into discrete nuclear domains. Accordingly, SMRTe synergizes with HDAC4 and 5 to inhibit MEF2C transactivation of target promoter, suggesting that nuclear domain targeting of HDAC4/5 may be important in preventing muscle cell differentiation. These results highlight an unexpected new function of the nuclear receptor corepressor SMRTe for its role in regulating cellular trafficking of nuclear receptor and selective HDACs that may play an important role in regulation of cell growth and differentiation.